Page 141 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis
P. 141

Genetic Aspects of Vasculitis   117

[158] Dogan, C. S., Akman, S., Koyun, M., et al. Prevalence and significance of the MEFV
       gene mutations in childhood Henoch-Schonlein purpura without FMF symptoms.
       Rheumatol. Int. 2013; 33:377-380.

[159] Gershoni-Baruch, R., Broza, Y., Brik, R. Prevalence and significance of mutations in
       the familial Mediterranean fever gene in Henoch-Schonlein purpura. J. Pediatr. 2003;
       143:658-661.

[160] Zhou, J., Tian, X., Xu, Q. Angiotensin-converting enzyme gene insertion/deletion
       polymorphism in children with Henoch-Schonlein purpua nephritis. J. Huazhong Univ.
       Sci. Technolog. Med. Sci. 2004; 24:158-161.

[161] Ozkaya, O., Soylemezoglu, O., Gonen, S., et al. Renin-angiotensin system gene
       polymorphisms: association with susceptibility to Henoch-Schonlein purpura and renal
       involvement. Clin. Rheumatol. 2006; 25:861-865.

[162] Desong, L., Fang, L., Songhui, Z., et al. Renin-angiotensin system gene polymorphisms
       in children with Henoch-Schonlein purpura in West China. J. Renin. Angiotensin.
       Aldosterone Syst. 2010; 11:248-255.

[163] Amoroso, A., Danek, G., Vatta, S., Crovella, S., Berrino, M., Guarrera, S., et al.
       Polymorphisms in angiotensin-converting enzyme gene and severity of renal disease in
       Henoch-Schoenlein patients. Italian Group of Renal Immunopathology. Nephrol. Dial.
       Transplant. 1998; 13:3184-3188.

[164] Dudley, J., Afifi, E., Gardner, A., et al. Polymorphism of the ACE gene in Henoch-
       Schonlein purpura nephritis. Pediatr. Nephrol. 2000; 14:218-220.

[165] Martin, J., Paco, L., Ruiz, M. P., et al. Inducible nitric oxide synthase polymorphism is
       associated with susceptibility to Henoch-Schonlein purpura in northwestern Spain. J.
       Rheumatol. 2005; 32:1081-1085.

[166] Rueda, B., Perez-Armengol, C., Lopez-Lopez, S., et al. Association between functional
       haplotypes of vascular endothelial growth factor and renal complications in Henoch-
       Schonlein purpura. J. Rheumatol. 2006; 33:69-73.

[167] Zeng, H. S., Xiong, X. Y., Chen, Y. Y., et al. Gene polymorphism of vascular
       endothelial growth factor in children with Henoch-Schonlein purpura nephritis.
       Zhongguo Dang Dai Er Ke Za Zhi 2009; 11:417-421.

[168] Yilmaz, A., Emre, S., Agachan, B., et al. Effect of paraoxonase 1 gene polymorphisms
       on clinical course of Henoch-Schonlein purpura. J. Nephrol. 2009; 22:726-732.

[169] Remmers, E. F., Cosan, F., Kirino, Y., et al. Genome-wide association study identifies
       variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with
       Behçet's disease. Nat. Genet. 2010; 42:698-702.

[170] Mizuki, N., Meguro, A., Ota, M., et al. Genome-wide association studies identify
       IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat. Genet. 2010; 42:
       703-706.

[171] Lee, Y. J., Horie, Y., Wallace, G. R., et al. Genome-wide association study identifies
       GIMAP as a novel susceptibility locus for Behçet's disease. Ann. Rheum. Dis. 2013; 72:
       1510-1516

[172] Hughes, T., Coit, P., Adler, A., et al. Identification of multiple independent
       susceptibility loci in the HLA region in Behçet's disease. Nat. Genet. 2013; 45:319-324.

[173] Ohno, S., Ohguchi, M., Hirose, S., et al. Close association of HLA-Bw51 with Behçet's
       disease. Arch. Ophthalmol. 1982; 100:1455-1458.

Complimentary Contributor Copy
   136   137   138   139   140   141   142   143   144   145   146